United States Anesthesia Drugs Market & Forecast

Publisher Name :
Date: 12-Jun-2017
No. of pages: 127
Inquire Before Buying

United States Anesthesia Market is expected to be more than US$ 4 Billion by 2022. This growth is driven by increasing incidence of cardiovascular cases, growing old age population and rising number of urgent surgeries in United States. Private as well as public health insurers also help to boost this market as they consider anesthetic products in their reimbursement policy.

General Intravenous Anesthesia is the Leading Segments in the United States Anesthesia Market

General intravenous anesthesia is the leading segments in the United States Anesthesia Market.  Propofol, Benzodiazepines Class, Fospropofol Disodium, Ketamine, Methohexital Sodium, Pentobarbital, Etomidate and Fentanyl are commonly used general intravenous anesthesia in the United States. Among these anesthesia, Propofol and Benzodiazepines Class are the leading anesthesia drugs which hold more than 75 percent combined market share in 2016.

Major Anesthesia Drug’s Manufacturers are continuously losing their Sales in United Sates

In the United States anesthesia drugs market several players are selling their products. Most of the anesthesia drugs sale are in generic form as it is available in the low cost.  However all major drugs manufactures such as AstraZeneca, AbbVie , Endo Healthcare etc. anesthesia products sales are turning down continuously. Only Baxter International anesthesia drugs sales are growing in the United States market.

United States Anesthesia Drugs Market & Forecast is the 2nd edition report on United States Anesthesia Market published by Renub Research. This 127 page report with 55 Figures and 16 Tables provides a detailed analysis of local and general anesthesia drugs market, health insurers’ anesthesia reimbursement policies, eligibility criteria and reimbursement methods in United States. This report has been studied from 8 viewpoints.


  • United Sates Anesthesia Market

  • United Sates Anesthesia Drugs Share Analysis

  • General Anesthesia Market

  • Local Anesthesia Market

  • Anesthesia Reimbursement Policy by Health Insurance Companies (Private & Public)

  • Major Companies Anesthesia Sales

  • United States Anesthesia Market Drivers

  • United States Anesthesia Market Challenges


General Intravenous Anesthetic Drugs Market has been further divided into


  • Propofol Market (2011 – 2022)

  • Benzodiazepines Class (Diazepam and Midazolam) (2011 – 2022)

  • Fospropofol Disodium (2011 – 2022)

  • Ketamine (2011 – 2022)

  • Methohexital Sodium (2011 – 2022)

  • Pentobarbital  (2011 – 2022)

  • Etomidate (2011 – 2022)

  • Fentanyl (2011 – 2022)


United States Local Anesthetic Market has been further divided into


  • Articane (2011 – 2022)

  • Bupivacaine (2011 – 2022)

  • Lidocaine (2011 – 2022)

  • Mepivacaine (2011 – 2022)

  • Prilocaine (2011 – 2022)


Key Players Sales in United States Anesthetic Drugs Market


  • Baxter International Inc (2011 – 2022)

  • Endo Health Solutions Inc (2011 – 2022)

  • AbbVie (2011 – 2022)

  • AstraZeneca (2011 – 2022)


This report provides the answer of following questions


  • Which one is the leading market (Local anesthesia or general Anesthesia) in the United States Anesthesia market?

  • Which is the leading local anesthesia drug in United States Local Anesthesia Market?

  • Which is the leading General anesthesia drug in United States General Anesthesia Market?

  • What is the market size of each anesthesia drugs during 2011 – 2022?

  • What is the reimbursement policy on anesthetic services in the United States?

  • What are the anesthesia drugs sales situations in United States for key anesthesia players?

  • What is the reimbursements policy in United States for Anesthesia by Private and Public Insurers

United States Anesthesia Drugs Market & Forecast

Table of Contents

1. Executive Summary

2. United States Anesthesia Drugs Market (2011 – 2022)

3. United States Anesthesia Drugs Market Share & Forecast (2011 – 2022)
3.1 United States Anesthesia Drugs Market Share & Forecast by Type (2011 – 2022)
3.2 United States General Intravenous Anesthesia Drugs Market Share & Forecast (2011 – 2022)
3.3 United States Local Anesthesia Drugs Market Share & Forecast (2011 – 2022)
3.4 United States Anesthesia Drugs Market Share & Forecast by Company (2011 – 2022)

4. By Type – United States Anesthesia Drugs Market (2011 – 2022)
4.1 United States General Inhalation Anesthesia Drugs Market (2011 – 2022)
4.2 United States General Intravenous Anesthesia Drugs Market (2011 – 2022)
4.3 United States Local Anesthesia Drugs Market (2011 – 2022)

5. By Drugs – United States General Intravenous Anesthesia Drugs Market (2011 – 2022)
5.1 United States Propofol Market (2011 – 2022)
5.2 United States Benzodiazepines Class (Diazepam and Midazolam) Market (2011 – 2022)
5.3 United States Fospropofol Disodium Market (2011 – 2022)
5.4 United States Ketamine Market (2011 – 2022)
5.5 United States Methohexital Sodium Market (2011 – 2022)
5.6 United States Pentobarbital Market (2011 – 2022)
5.7 United States Etomidate Market (2011 – 2022)
5.8 United States Fentanyl Market (2011 – 2022)

6. By Drugs – United States Local Anesthesia Drugs Market (2011 – 2022)
6.1 United States Articaine Market (2011 – 2022)
6.2 United States Bupivacaine Market (2011 – 2022)
6.3 United States Lidocaine Market (2011 – 2022)
6.4 United States Mepivacaine Market (2011 – 2022)
6.5 United States Prilocaine Market (2011 – 2022)

7. Key Players Profile in United States Anesthesia Drugs Market
7.1 Baxter International Inc. Anesthesia Drugs Sales & Forecast (2011 – 2022)
7.2 Endo Health Solutions Inc. Anesthesia Drugs Sales & Forecast (2011 – 2022)
7.3 AbbVie Anesthesia Drugs Sales & Forecast (2011 – 2022)
7.4 AstraZeneca Anesthetic Drugs Sales (2009 – 2011)

8. United States Anesthesia market Merger & Acquisition (M&A)

9. United States Anesthesia Reimbursement Policy - Private Health Insurance Providers
9.1 Aetna International
9.2 Coventry Health Care
9.3 Anthem Blue Cross and Blue Shield
9.4 Blue Cross and Blue Shield of Texas
9.5 UnitedHealthcare
9.5.1 State Exceptions

10. United States Anesthesia Reimbursement Policy – Public Health Insurance Providers
10.1 Medicare
10.2 MDWise

11. United States Anesthesia Drugs Market – Growth Drivers
11.1 Growing Demand for Anesthesia Service
11.2 Rise in Ageing Population & Prevalence of Cardiovascular Disease in United States
11.2.1 Rise in Ageing Population

12. United States Anesthesia Drugs Market – Challenges
12.1 Un-match Anesthesia Providers in United States
12.2 Shortage of Anesthesia Drugs in United States

List of Tables

Table 8‑1: United States – Anesthesia Market Merger & Acquisitions (M&A), Jan 2016 – March 2017
Table 9‑1: Coventry Health Care - Anesthesia Modifiers, 2016
Table 9‑2: Blue Cross and Blue Shield of Texas - Physical Status Modifiers, 2017
Table 9‑3: Blue Cross and Blue Shield of Texas - Qualifying Circumstances, 2017
Table 9‑4: Blue Cross and Blue Shield of Texas - Modifier Information Billed by an Anesthesiologist, 2017
Table 9‑5: Blue Cross and Blue Shield of Texas - Modifier Information Billed by a CRNA, 2017
Table 9‑6: Blue Cross and Blue Shield of Texas - Anesthesia Modifier Reimbursement
Table 9‑7: UnitedHealthcare Community – Modifiers, 2017
Table 10‑1: Medicare - Reimbursement Formulas
Table 10‑2: Medicare - General and Monitored Anesthesia Care
Table 10‑3: Medicare - Anesthesia Modifiers, 2017
Table 10‑4: MDwise –Type of Service & PA Requirement
Table 10‑5: MDwise - Anesthesia Time Table, 2017
Table 10‑6: MDwise - Qualifying Circumstances, 2017
Table 10‑7: MDwise - Status Modifiers, 2017
Table 11‑1: United States – Cardiovascular Disease Prevalence (Percent), 2010,2015,2020,2025, 2030

List of Figures

Figure 2‑1: United States – Anesthesia Drugs Market (Million US$), 2011 – 2016
Figure 2‑2: United States – Forecast for Anesthesia Drugs Market (Million US$), 2017 – 2022
Figure 3‑1: United States – Anesthesia Drugs Market Share by Type (Percent), 2011 – 2016
Figure 3‑2: United States – Forecast for Anesthesia Drugs Market Share by Type (Percent), 2017 – 2022
Figure 3‑3: United States – General Intravenous Anesthesia Drugs Market Share (Percent), 2011 – 2016
Figure 3‑4: United States – Forecast for General Intravenous Anesthesia Drugs Market Share (Percent), 2017 – 2022
Figure 3‑5: United States – Local Anesthesia Drugs Market Share (Percent), 2011 – 2016
Figure 3‑6: United States – Forecast for Local Anesthesia Drugs Market Share (Percent), 2017 – 2022
Figure 3‑7: United States – Anesthesia Drugs Market Share by Company (Percent), 2011 – 2016
Figure 3‑8: United States – Forecast for Anesthesia Drugs Market Share by Company (Percent), 2017 – 2022
Figure 4‑1: United States – General Inhalation Anesthesia Drugs Market (Million US$), 2011-2016
Figure 4‑2: United States – Forecast for General Inhalation Anesthesia Drugs Market (Million US$), 2017 – 2022
Figure 4‑3: United States – General Intravenous Anesthesia Drugs Market (Million US$), 2011 – 2016
Figure 4‑4: United States – Forecast for General Intravenous Anesthesia Drugs Market (Million US$), 2017 – 2022
Figure 4‑5: United States – Local Anesthesia Drugs Market (Million US$), 2011-2016
Figure 4‑6: United States – Forecast for Local Anesthesia Drugs Market (Million US$), 2017 – 2022
Figure 5‑1: United States – Propofol Market (Million US$), 2011 – 2016
Figure 5‑2: United States – Forecast for Propofol Market (Million US$), 2017 – 2022
Figure 5‑3: United States – Benzodiazepines Class Market (Million US$), 2011 – 2016
Figure 5‑4: United States – Forecast for Benzodiazepines Class Market (Million US$), 2017 – 2022
Figure 5‑5: United States – Fospropofol Disodium Market (Million US$), 2011 – 2016
Figure 5‑6: United States – Forecast for Fospropofol Disodium Market (Million US$), 2017 – 2022
Figure 5‑7: United States – Ketamine Market (Million US$), 2011 – 2016
Figure 5‑8: United States – Forecast for Ketamine Market (Million US$), 2017 – 2022
Figure 5‑9: United States – Methohexital Sodium Market (Million US$), 2011 – 2016
Figure 5‑10: United States – Forecast for Methohexital Sodium Market (Million US$), 2017 – 2022
Figure 5‑11: United States – Pentobarbital Market (Million US$), 2011 – 2016
Figure 5‑12: United States – Forecast for Pentobarbital Market (Million US$), 2017 – 2022
Figure 5‑13: United States – Etomidate Market (Million US$), 2011 – 2016
Figure 5‑14: United States – Forecast for Etomidate Market (Million US$), 2017 – 2022
Figure 5‑15: United States – Fentanyl Market (Million US$), 2011 – 2016
Figure 5‑16: United States – Forecast for Fentanyl Market (Million US$), 2017 – 2022
Figure 6‑1: United States – Articaine Market (Million US$), 2011-2016
Figure 6‑2: United States – Forecast for Articane Market (Million US$), 2017 – 2022
Figure 6‑3: United States – Bupivacaine Market (Million US$), 2011-2016
Figure 6‑4: United States – Forecast for Bupivacaine Market (Million US$), 2017 – 2022
Figure 6‑5: United States – Lidocaine Market (Million US$), 2011-2016
Figure 6‑6: United States – Forecast for Lidocaine Market (Million US$), 2017 – 2022
Figure 6‑7: United States – Mepivacaine Market (Million US$), 2011-2016
Figure 6‑8: United States – Forecast for Mepivacaine Market (Million US$), 2017 – 2022
Figure 6‑9: United States – Prilocaine Market (Million US$), 2011-2016
Figure 6‑10: United States – Forecast for Prilocaine Market (Million US$), 2017 – 2022
Figure 7‑1: United States – Baxter International Anesthesia Drugs Sales (Million US$), 2011-2016
Figure 7‑2: United States – Forecast for Baxter International Anesthesia Drugs Sales (Million US$), 2017 – 2022
Figure 7‑3: United States – Endo Health Solutions Anesthesia Drugs Sales (Million US$), 2011-2016
Figure 7‑4: United States – Forecast for Endo Health Solutions Anesthesia Drugs Sales (Million US$), 2017 – 2022
Figure 7‑5: United States – AbbVie Anesthesia Drugs Sales (Million US$), 2011 - 2016
Figure 7‑6: United States – Forecast for AbbVie Anesthesia Drugs Sales (Million US$), 2017 – 2022
Figure 7‑7: United States – AstraZeneca Anesthesia Drugs Sales (Million US$), 2009 – 2011
Figure 11‑1: United States – Cosmetic Procedures (Number), 1997, 2012-2013, 2015-2016
Figure 11‑3: United States – Ageing Population by Age Group (Thousand), 2012 – 2016
Figure 12‑1: United States – By Region Availability of Anesthesia Specialists (Percent), 2010
Figure 12‑2: United States – By States Availability of Anesthesia Specialists (Percent), 2010
Figure 12‑3: United States – Drugs Shortage (Number), 2001-2015
Figure 12‑4: United States – Anesthesia Drugs Shortage with the Highest Frequency (Percent), 2012

  • Global Sevoflurane Market Growth 2020-2025
    Published: 24-Feb-2020        Price: US 3660 Onwards        Pages: 132
    According to this study, over the next five years the Sevoflurane market will register a -0.5% CAGR in terms of revenue, the global market size will reach $ 1280.5 million by 2025, from $ 1307.5 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Sevoflurane business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Sevoflurane market by type, application,......
  • Global Remifentanil Hydrochloride Market Analysis 2015-2019 and Forecast 2020-2025
    Published: 20-Feb-2020        Price: US 2980 Onwards        Pages: 80
    Snapshot The global Remifentanil Hydrochloride market size is estimated at xxx million USD with a CAGR xx% from 2015-2019 and is expected to reach xxx Million USD in 2020 with a CAGR xx% from 2020 to 2025. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Remifentanil Hydrochloride by product, region and application, in addition, this report introduces market competition situation among the ve......
  • Global Sevoflurane Market Data Survey Report 2015-2025
    Published: 13-Feb-2020        Price: US 1500 Onwards        Pages: 60
    Summary The global Sevoflurane market will reach xxx Million USD in 2020 with CAGR xx% 2020-2025. The main contents of the report including: Global market size and forecast Regional market size, production data and export & import Key manufacturers profile, products & services, sales data of business Global market size by Major End-Use Global market size by Major Type Key manufacturers are included based on company profile, sales d......
  • Global Remifentanil Hydrochloride Market Data Survey Report 2015-2025
    Published: 10-Feb-2020        Price: US 1500 Onwards        Pages: 60
    Summary The global Remifentanil Hydrochloride market will reach xxx Million USD in 2020 with CAGR xx% 2020-2025. The main contents of the report including: Global market size and forecast Regional market size, production data and export & import Key manufacturers profile, products & services, sales data of business Global market size by Major End-Use Global market size by Major Type Key manufacturers are included based on company p......
  • Global General Anesthesia Drugs Market Growth 2020-2025
    Published: 10-Feb-2020        Price: US 3660 Onwards        Pages: 163
    According to this study, over the next five years the General Anesthesia Drugs market will register a 2.8% CAGR in terms of revenue, the global market size will reach $ 7514.3 million by 2025, from $ 6728.2 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in General Anesthesia Drugs business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of General Anesthe......
  • Global Remifentanil Hydrochloride Market Growth 2020-2025
    Published: 05-Feb-2020        Price: US 3660 Onwards        Pages: 132
    According to this study, over the next five years the Remifentanil Hydrochloride market will register a xx% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Remifentanil Hydrochloride business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Remifentanil Hydroch......
  • Global General Anaesthesia Drugs Market Size, Status and Forecast 2020-2026
    Published: 28-Jan-2020        Price: US 3900 Onwards        Pages: 99
    This report focuses on the global General Anaesthesia Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the General Anaesthesia Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America. The key players covered in this study - Baxter International - AstraZeneca - Abbott Laboratories - Roche - Fresenius - Mylan - Eisai......
  • Global Sevoflurane Market Analysis 2015-2019 and Forecast 2020-2025
    Published: 27-Jan-2020        Price: US 2980 Onwards        Pages: 100
    Snapshot The global Sevoflurane market size is estimated at xxx million USD with a CAGR xx% from 2015-2019 and is expected to reach xxx Million USD in 2020 with a CAGR xx% from 2020 to 2025. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Sevoflurane by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, bes......
  • Global Sevoflurane Source Market Size, Status and Forecast 2020-2026
    Published: 22-Jan-2020        Price: US 3900 Onwards        Pages: 95
    This report focuses on the global Sevoflurane Source status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Sevoflurane Source development in Europe, USA, Japan and China. The key players covered in this study - Abbott - Baxter - Maruishi - Jiangsu Hengrui - Lunan - ... Market segment by Type, the product can be split into - Animals - Children Mar......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs